CClinicalTrials.gg
CompletedNCT02072980Updated May 14, 2015Results posted

DAILIES TOTAL1® Lubricity Post Wear

An interventional study of Delefilcon A contact lenses in Refractive Error, sponsored by Alcon Research. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-05-14.

Sponsored by Alcon Research · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The primary objective of the study is to demonstrate that the lubricity of DAILIES TOTAL1® (DT1) lenses after 16 hours of wear is equivalent to the lubricity of unworn DT1 lenses.

Read the detailed description

In this study, participants wore study lenses for 2 specified time periods (16 hours and 15 minutes, treatment sequence randomized) following which lenses were collected for ex vivo lubricity analysis. The ex vivo lubricity analysis was evaluated under a separate non-clinical protocol.

02

Conditions studied

  • Refractive Error

Browse trials for

Keywords

  • DT1
  • DAILIES TOTAL1®
  • Lubricity
03

In context

Refractive Errors

413 studies on the registry are indexed under Refractive Errors; 62 are open to participants now.

This study's enrollment of 15 is below the median of 82 across 296 interventional studies indexed under Refractive Errors.

Browse Refractive Errors studies →

Lead sponsor

Alcon Research is the lead sponsor of 608 studies on the registry; 9 are open to participants now.

Of its 109 completed or terminated interventional studies of FDA-regulated products, 99 (91%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Willing and able to sign Informed Consent document.
  • Adapted, current soft contact lens wearer.
  • Requires contact lens powers within the specified range of -0.50 diopters (D) to -10.00D.
  • Cylinder between 0.00D and -1.00D (inclusive) in both eyes at Visit 1 manifest refraction.
  • Vision correctable to 20/25 or better in each eye at distance with study lenses.
  • Willing to wear study lenses at least 16 waking hours in one day and attend all study visits.
  • Able to be successfully fitted with study lenses.
  • Other protocol-specified inclusion criteria may apply.

Exclusion criteria

Exclusion Criteria:

  • Any ocular infection, inflammation, abnormality or active disease that would contraindicate contact lens wear, as determined by the Investigator.
  • Use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator.
  • Use of artificial tears and rewetting drops during the study.
  • Monocular (only one eye with functional vision) or fit with only one lens.
  • Any abnormal ocular condition observed during the Visit 1 slit lamp examination.
  • History of herpetic keratitis, ocular surgery, or irregular cornea.
  • Pregnant.
  • Participation in any clinical study within 30 days of Visit 1.
  • Other protocol-specified exclusion criteria may apply.
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Other
    16hrs/15mins

    Delefilcon A contact lenses worn bilaterally (in both eyes) for 16 waking hours (1 day) in Period 1, followed by 15 minutes in Period 2. A fresh pair of lenses was dispensed for Period 2.

    Device: Delefilcon A contact lenses

  • Other
    15mins/16hrs

    Delefilcon A contact lenses worn bilaterally for 15 minutes in Period 1, followed by 16 waking hours (1 day) in Period 2. A fresh pair of lenses was dispensed for Period 2.

    Device: Delefilcon A contact lenses

Interventions

  • DeviceDelefilcon A contact lenses

    Silicone hydrogel contact lenses

    Also known as: DAILIES TOTAL1®

06

What researchers measure

Primary outcomes

  1. Average Coefficient of Friction (CF) at 16 Hours Compared to Unworn

    Worn contact lenses were removed from the participant's eye. The CF was calculated and compared to the CF for unworn contact lenses. A lower CF may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.

    Time frame: Day 1 (for each period), 16 hours

Secondary outcomes

  1. Average Coefficient of Friction at 15 Minutes

    Worn contact lenses were removed from the participant's eye and the CF was calculated. A lower CF may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.

    Time frame: Day 1 (for each period), 15 minutes

07

Results

Posted May 14, 2015

Participant flow

Participants were recruited from 1 study center located in the US.

Period 1, First Wear
Participant flow — Period 1, First Wear
Milestone16hr/15min15min/16hr
Started78
Completed78
Not completed00
Period 2, Second Wear
Participant flow — Period 2, Second Wear
Milestone16hr/15min15min/16hr
Started78
Completed77
Not completed01
Withdrew: Adverse event01

Outcome measures

PrimaryAverage Coefficient of Friction (CF) at 16 Hours Compared to Unworn

Worn contact lenses were removed from the participant's eye. The CF was calculated and compared to the CF for unworn contact lenses. A lower CF may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.

Time frame:
Day 1 (for each period), 16 hours
Reported as:
Mean · unitless
Average Coefficient of Friction (CF) at 16 Hours Compared to Unworn
unitless16 HoursUnworn
Average Coefficient of Friction (CF) at 16 Hours Compared to Unworn0.0394 ± 0.00150.0396 ± 0.0027
SecondaryAverage Coefficient of Friction at 15 Minutes

Worn contact lenses were removed from the participant's eye and the CF was calculated. A lower CF may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.

Time frame:
Day 1 (for each period), 15 minutes
Reported as:
Mean · unitless
Average Coefficient of Friction at 15 Minutes
unitless15 Minutes
Average Coefficient of Friction at 15 Minutes0.0392 ± 0.0017

Adverse events

Collected over Adverse events (AEs) were collected for the duration of the study (March 2014 - April 2014). This analysis population includes all participants exposed to the investigational product, based on treatment-specific exposure.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
DAILIES TOTAL1—0/15 (0%)2/15 (13.3%)
Most frequent other events
Most frequent other events
EventDAILIES TOTAL1
Corneal infiltratesEye disorders1/15
Ocular discomfortEye disorders1/15

Baseline characteristics

This analysis population includes all randomized participants.

Age, Continuous
Age, Continuous(years)Overall
Mean44.9 ± 10.91
Sex: Female, Male
Sex: Female, Male(Participants)Overall
Female9
Male6
08

Study locations

No study locations are listed for this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02072980
Lead sponsor
Alcon Research
Responsible party
Sponsor
First posted
Feb 27, 2014
Start date
Mar 2014
Primary completion
Apr 2014
Completion
Apr 2014
Results posted
May 14, 2015
Last update
May 14, 2015

Study contacts

Lisa L. Zoota, MPH, CCRA
study director · Alcon Research

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion